◆ TICKERBASEVista interattiva →
◆ TICKERBASE · GLOBAL STOCK FINANCIAL DATA LIBRARY

HomeTutte le azioni › ANTHEM · English version

Anthem Biosciences Limited (ANTHEM)

Storico di ricavi, utili e flussi di cassa dai bilanci ufficiali.

Healthcare · Wall Street (USA) · Ultimo aggiornamento: 2026-09-20

Anthem Biosciences Limited operates as a contract research, development, and manufacturing organization in India, rest of Asia, North America, Europe, and internationally. It operates in two segments: Contract Manufacturing, Development & Discovery Services; and Speciality Ingredients.

Dati chiave

Vedi grafici interattivi e bilanci completi →

Conto economico annuale

Conto economico2026-03-312025-03-312024-03-312023-03-312022-03-31
Entrate totali₹21.2B₹18.4B₹14.2B₹10.6B
Utile lordo₹13.1B₹11.0B₹8.2B₹7.2B
Risultato Operativo (EBIT)₹7.1B₹5.9B₹4.2B₹3.7B
Reddito netto₹5.9B₹4.5B₹3.7B₹3.9B

Fonte: bilanci pubblici della società (SEC). Verificare su SEC EDGAR prima di fare affidamento su qualsiasi cifra.

Stati patrimoniali, flussi di cassa, dati trimestrali e indici completi nel visualizzatore interattivo di ANTHEM. /companies/us/ANTHEM

Aziende simili

Le informazioni di questo sito sono solo a scopo educativo e informativo; non costituiscono consulenza finanziaria. Non vengono pubblicati prezzi obiettivo né raccomandazioni.

English version →Tutte le azioni

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.